A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinica
опубликовано в: Respiratory Medicine
дата публикации: 2020-11-29
Cites articles
There is nothing here
Статья - wd:Q104070686